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Background
Aborted sudden cardiac death (SCD) is a common indi-
cation for CMR. No studies have investigated the prog-
nostic value of late gadolinium enhancement (LGE)
solely in patients with secondary prevention implantable
cardioverter-defibrillators (ICD) or aborted SCD.
Methods
58 consecutive patients who had CMR and ICD implan-
tation after aborted SCD between 2006 and 2013 were
identified. Clinical notes and CMR results were
reviewed. Patients were scanned with a CMR protocol
that included a short axis cine stack and LGE imaging.
CMR images were analysed blinded to clinical data
using standard software (cvi42, Circle CVI, Canada).
Patients were followed up after ICD implantation at six
weeks, three months and six months and then every six
months. Appropriate ICD therapy was defined as any
anti-tachycardia pacing (ATP) or shock therapy deliv-
ered for a ventricular arrhythmia.
Results
Follow up data was available on 55/58 patients. Four
patients died during the follow up period and one
patient was lost to follow up 14 days post-implantation.
Median follow up was 791 days (interquartile range 370-
1142 days). 11 patients had appropriate ICD therapy.
6 had ATP only and 5 had appropriate shocks ±ATP for
ventricular arrhythmias. The clinical aetiology of the
aborted SCD was ischaemic heart disease (IHD) 24, pri-
mary arrhythmia 14, arrhythmogenic right ventricular
cardiomyopathy 7, dilated cardiomyopathy 6, myocardi-
tis 2 and other 5.
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Figure 1 Kaplan Meier curves showing freedom from appropriate ICD
therapy with patients stratified according to presence of LGE (above)
and EF (below). Each horizontal line represents a censored subject.
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Of 55 patients on whom clinical outcome data was
available 20 patients had ejection fraction (EF)<35% and
35 had EF>35%. 5/20 (25%) of those with EF<35% had
appropriate ICD therapies and 6/35 (17%) of those with
EF>35% had appropriate ICD therapies on follow up.
There was no significant difference in the likelihood
ratio (LR) of appropriate therapy using an EF cutoff of
35% (LR 0.48, P=0.49), confirmed on log rank analysis
of Kaplan Meier curves (figure 1) (P=0.32).
Of the 52 patients who had LGE imaging and clinical
outcome data 32 had LGE present and 20 had no LGE.
10/32 (31%) LGE +ve patients had appropriate ICD
therapies on follow up and only 1/20 (5%) LGE-ve
patients had appropriate ICD therapies. LGE +ve
patients were significantly more likely to have an appro-
priate ICD therapy on follow up (LR 5.97, P=0.015),
confirmed on log rank analysis of Kaplan Meier curves
(P=0.036).
Conclusions
In patients who have suffered aborted SCD, CMR is able
to identify patients at risk of future arrhythmic events
according to the presence or absence of LGE.
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